Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Iot symbols : AZNCF save search
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate, Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting
Published: 2022-03-21 (Crawled : 13:30) - biospace.com/
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -4.79%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 2.03%
H: 0.66%
C: -5.96%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
cutx-101 america genetic therapeutics biotech iot
Fortress Biotech to Participate in Three March 2022 Investor Conferences
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.32%
H: 7.71%
C: 5.4%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 1.52%
H: 8.21%
C: 8.21%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 3.16%
H: 3.23%
C: 2.95%
conference biotech iot
Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
Published: 2022-03-03 (Crawled : 14:00) - biospace.com/
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: -7.74%
H: 0.55%
C: -2.58%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -2.63%
H: 0.9%
C: -0.3%
day ces biotech iot
Fortress Biotech to Ring Nasdaq Stock Market Closing Bell on December 21
Published: 2021-12-21 (Crawled : 01:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 3.52%
H: 2.27%
C: 2.27%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 1.92%
H: 2.26%
C: -0.38%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.19%
H: 0.94%
C: 0.48%
nasdaq biotech iot
Fortress Biotech Announces Initiation of Phase 2 Clinical Trial of Triplex for Adults Co-Infected with HIV and CMV
Published: 2021-12-16 (Crawled : 13:30) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 1.5%
H: 1.71%
C: 1.71%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: -5.34%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 2.13%
H: 1.9%
C: 1.73%
phase 2 trial biotech iot hiv infections
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for Treatment of Menkes Disease
Published: 2021-12-07 (Crawled : 13:30) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -2.48%
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: 7.0%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -2.08%
H: 1.18%
C: 1.13%
new drug treatment application drug therapeutics disease biotech iot submission
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.